Workflow
华泰瑞银(08006) - 2025 - 年度业绩
2025-10-31 08:31
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 中國華泰瑞銀控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:8006) 截至二零一二年十二月三十一日及 二零一三年十二月三十一日止年度之 年報之補充公告 茲提述中國華泰瑞銀控股有限公司(「本公司」,連同其附屬公司統稱「本集團」) 分別於二零一三年三月二十二日及二零一四年三月十三日刊發的截至二零一二 年十二月三十一日止年度之年報(「二零一二年年報」)及截至二零一三年十二月 三十一日止年度之年報(「二零一三年年報」)。除另有界定者外,本公告所用詞彙 與該等年報所界定者具有相同涵義。 董事會謹此就該等年報所載綜合財務報表披露的已付或應付董事及最高行政人員 酬金提供補充資料。 最高行政人員姓名 本公告僅供參考,並不構成收購、購買或認購本公司證券的邀請或要約。 Sino Splendid Holdings Limited 除上述澄清資料外,二零一二年年報及二零一三年年報所載之所有資料及內容維 持不變。 ...
香港宽频(01310) - 2025 - 年度业绩
2025-10-31 08:30
香港交易及結算所有限公司和香港聯合交易所有限公司對本公告的內容 概 不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示 概 不 就 因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損 失 承 擔 任 何 責 任。 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 (股份代號: 1310) HKBN Ltd. 香 港 寬 頻 有 限 公 司 截 至2025 年8 月31 日止年度 全年業績公告 (除 另 有 說 明 外,本 公 告 所 載 有 的 全 部 財 務 數 字 均 以 港 元 列 示。) 香 港 寬 頻 有 限 公 司(「本公司」)董 事 會(「董事會」)欣 然 公 佈 本 公 司 及 其 附 屬 公 司(「本集團」)截 至2025 年8 月31 日 止 年 度(「2025 財 年」)的 綜 合 業 績。 公告摘要 – 1 – ) • 總 收 益 表 現 強 勁,按 年 增 長4%至111.29 億 元。尤 其 亮 眼 的 是,在 撇 除 手 機 及 其 他 產 品 銷 售 後,核 心 服 務 收 益 增 幅7%。 • 息稅折舊攤銷 ...
十方控股(01831) - 2025 - 年度财报
2025-10-31 08:01
年 報 ANNUAL REPORT 2024 2024 // CORPORATE INFORMATION 公司資料 DIRECTORS Executive Directors Mr. Chen Zhi (Chairman & Chief Executive Officer) Mr. Chen Ye (redesignated from Non-executive Director as on 2023.06.30) Mr. Yu Shiquan (retired as on 2023.06.30) Mr. Wang Xu (appointed as on 2023.01.09 and retired as on 2023.06.30) Non-executive Directors Ms. Wang Bao Zhu (appointed as on 2023.06.30) Mr. Chen Ye (appointed as on 2023.01.09 and redesignated to Executive Director as on 2023.06.30) Ms. Chen Min (retired a ...
德利机械(02102) - 2025 - 年度财报
2025-10-31 07:17
TAK LEE MACHINERY HOLDINGS LIMITED 德 利 機 械 控 股 有 限 公 司 股份代號:2102 (於開曼群島註冊成立的有限公司) 年報 2025 目錄 公司秘書 吳慧瑩女士 授權代表 周聯發先生 吳慧瑩女士 公司資料及重要日期 2 主席報告 6 管理層討論及分析 8 董事及高級管理層 13 董事會報告 17 企業管治報告 30 獨立核數師報告 45 綜合損益及其他全面收益表 52 綜合財務狀況表 53 綜合權益變動表 54 綜合現金流量表 55 綜合財務報表附註 57 五年財務概要 116 公司資料 及重要日期 董事會 執行董事 周聯發先生 (主席兼行政總裁) 廖淑儀女士 吳慧瑩女士 非執行董事 鄭如雯女士 獨立非執行董事 郭兆文黎剎騎士勳賢 羅子璘先生 黃文顯博士 薪酬委員會 總部及香港主要營業地點 董事委員會 審核委員會 羅子璘先生 (主席) 郭兆文黎剎騎士勳賢 黃文顯博士 黃文顯博士 (主席) 郭兆文黎剎騎士勳賢 羅子璘先生 提名委員會 郭兆文黎剎騎士勳賢 (主席) 羅子璘先生 黃文顯博士 吳慧瑩女士 (於二零二五年三月二十一日獲委任) 註冊辦事處 Cricket Sq ...
奇瑞汽车(09973) - 2025 Q3 - 季度业绩
2025-10-31 04:19
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因依賴 該等內容而引致的任何損失承擔任何責任。 Chery Automobile Co., Ltd. 奇瑞汽車股份有限公司 (於中華人民共和國註冊成立的股份有限公司) (股份代號:9973) 2025年第三季度報告 本公告乃由奇瑞汽車股份有限公司(「本公司」,連同其附屬公司「本集團」)根據香 港聯合交易所有限公司證券上市規則第13.09(2)條及香港法例第571章證券及期貨 條例第XIVA部刊發。 為向股東及投資者提供本集團的最新資料,本公司董事(「董事」)會(「董事會」) 謹此宣佈本集團截至2025年9月30日止九個月(「期間」)的未經審計財務數據。 1 簡明合併損益表 截至2025年9月30日止九個月 截至9月30日止九個月 | | 2025年 | 2024年 | | --- | --- | --- | | | 人民幣百萬元 | 人民幣百萬元 | | | (未經審計) | (未經審計) | | 收入 | 214,833 | 182,154 | | ...
鞍钢股份(00347) - 2025 Q3 - 季度业绩
2025-10-30 14:50
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 (股份編號:0347) 2025年第三季度報告 本 公 司 及 董 事 會 全 體 成 員 保 證 信 息 披 露 的 內 容 真 實、準 確、完 整,沒 有 虛 假 記 載、誤 導 性 陳 述 或 重 大 遺 漏。 重 要 內 容 提 示: 董事、高級管理人員是否存在對季度報告內容存在異議或無法保證其真實、 準 確、完 整 的 情 況 – 1 – 是 ✓ 否 1. 董 事 會 及 董 事、高 級 管 理 人 員 保 證 季 度 報 告 的 真 實、準 確、完 整,不 存在虛假記載、誤導性陳述或重大遺漏,並承擔個別和連帶的法律責任。 2. 公 司 負 責 人 王 軍 先 生、主 管 會 計 工 作 負 責 人 李 景 東 先 生 及 會 計 機 構 負責人馬莉女士聲明:保證季度報告中財務信息的真實、準確、完整。 3. 第三季度財務會計報 ...
昭衍新药(06127) - 2025 Q3 - 季度业绩
2025-10-30 14:48
Financial Performance - Total revenue for the third quarter was RMB 316,386,319, a decrease of 34.87% compared to the same period last year[9]. - Net profit attributable to shareholders was RMB 19,773,669, down 80.11% year-on-year[9]. - Basic earnings per share decreased by 76.92% to RMB 0.03[9]. - Operating revenue decreased by 26.23% year-to-date due to market competition and a decline in sales order prices[16]. - Total profit increased by 242.54% year-to-date, primarily due to a decrease in gross profit and the dual impact of changes in the fair value of biological assets[16]. - Net profit attributable to shareholders increased by 214.79% year-to-date, influenced by lower gross profit and changes in the fair value of biological assets[16]. - Total profit for the current reporting period decreased by 81.85%, primarily due to compressed profit margins from sales orders and decreased contributions from laboratory services[17]. - Net profit attributable to shareholders for the current reporting period decreased by 80.11%, influenced by similar factors affecting total profit[17]. - The net profit from laboratory services for the year-to-date period was a loss of RMB 156,891,000, a significant decrease of 9,101.32% year-on-year[12]. - The net profit excluding non-recurring gains and losses for the year-to-date period was RMB 29,044,731, a decrease of 92.94%[9]. Assets and Liabilities - Total assets at the end of the reporting period were RMB 9,533,382,709, an increase of 1.46% from the previous year[9]. - The total liabilities increased to RMB 1.41 billion as of September 30, 2025, compared to RMB 1.32 billion at the end of 2024[25]. - The total non-current assets decreased to RMB 4.22 billion from RMB 4.36 billion, showing a decline of approximately 3.2%[24]. - The company's fixed assets increased to RMB 780.36 million from RMB 696.79 million, reflecting a growth of about 12%[24]. - The contract liabilities rose to RMB 978.97 million from RMB 827.16 million, indicating a growth of approximately 18.4%[25]. Cash Flow - The company's cash flow from operating activities for the year-to-date period was RMB 266,391,149, an increase of 38.51%[9]. - Net cash flow from operating activities increased by 38.51% year-to-date, mainly due to a decrease in cash payments for goods and taxes[16]. - Operating cash inflow for the first three quarters of 2025 was CNY 1,323,471,987.19, a decrease of 3.2% compared to CNY 1,367,691,390.73 in the same period of 2024[35]. - Cash inflow from investment activities totaled CNY 1,966,983,491.98, down 21.5% from CNY 2,508,098,115.21 in 2024[36]. - Net cash flow from investment activities was negative at CNY -264,722,612.49, an improvement from CNY -950,050,766.71 in the previous year[36]. - Cash outflow from financing activities decreased significantly to CNY 58,988,545.91 in 2025, compared to CNY 248,828,091.97 in 2024[37]. - The net increase in cash and cash equivalents for the first three quarters of 2025 was CNY -63,142,619.75, a notable improvement from CNY -1,013,522,516.10 in 2024[37]. - The ending balance of cash and cash equivalents as of September 2025 was CNY 902,060,508.84, down from CNY 1,840,124,511.87 in 2024[37]. Shareholder Information - The total number of common shareholders at the end of the reporting period was 96,458[19]. - The total equity attributable to shareholders increased by 0.52% to RMB 8,120,652,590[9]. - The total equity attributable to shareholders as of September 30, 2025, was CNY 8,120,652,590.12, slightly up from CNY 8,078,818,586.72 at the end of 2024[26]. - The total liabilities and equity amounted to CNY 9,533,382,709.22 as of September 30, 2025, compared to CNY 9,396,152,610.45 at the end of 2024[26]. Income and Expenses - Total operating revenue for the first three quarters of 2025 was CNY 984,961,529.76, a decrease of 26.1% compared to CNY 1,335,156,050.40 in the same period of 2024[28]. - Total operating costs for the first three quarters of 2025 were CNY 1,025,427,901.11, down from CNY 1,227,734,251.03 in 2024, reflecting a reduction of 16.5%[28]. - The net profit for the first three quarters of 2025 was CNY 80,706,047.32, compared to a net loss of CNY 74,244,009.94 in the same period of 2024[29]. - The comprehensive income total for the first three quarters of 2025 was CNY 74,225,826.90, a significant improvement from a loss of CNY 79,103,195.69 in 2024[31]. - Basic and diluted earnings per share for the first three quarters of 2025 were both CNY 0.11, compared to a loss of CNY 0.09 per share in 2024[31]. - Other income increased to CNY 24,712,928.01 in 2025 from CNY 19,124,400.35 in 2024, marking a growth of 29.0%[29]. - Investment income decreased to CNY 20,033,342.30 in 2025 from CNY 31,620,189.62 in 2024, a decline of 36.8%[29]. - The company reported a decrease in research and development expenses to CNY 63,864,270.44 in 2025 from CNY 71,085,657.06 in 2024, a reduction of 10.0%[28].
马鞍山钢铁股份(00323) - 2025 Q3 - 季度业绩
2025-10-30 14:47
Financial Performance - The company's operating revenue for the reporting period was CNY 19,496,655,926, representing a year-on-year increase of 5.35%[7] - The total profit for the reporting period was CNY 365,974,032, while the net profit attributable to shareholders was CNY 158,409,222[7] - The basic earnings per share for the reporting period was CNY 0.02, compared to CNY 0.01 for the same period last year[7] - The company reported a net profit attributable to shareholders, excluding non-recurring gains and losses, of CNY 176,264,998 for the reporting period[7] - The total profit of Maanshan Iron & Steel Co., Ltd. was approximately RMB 296 million during the reporting period[17] - The total comprehensive income for the first nine months of 2025 was RMB 355.63 million, compared to a loss of RMB 2.78 billion in 2024, showing a strong recovery in overall financial performance[26] - The total profit for the first nine months of 2025 was RMB 483.69 million, a substantial recovery from a loss of RMB 2.62 billion in the same period of 2024[25] - Net profit attributable to the parent company for the first nine months of 2025 was RMB 83.63 million, compared to a loss of RMB 2.53 billion in 2024, indicating a significant turnaround[25] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 69.60%, amounting to CNY 4,324,134,550[7] - The company reported a net cash flow from operating activities of RMB 4.32 billion for the first nine months of 2025, an increase from RMB 2.55 billion in the same period of 2024, representing a growth of 69.83%[28] - The cash flow from operating activities was not detailed in the provided data, but the overall cash position improved significantly[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 83,199,735,142, reflecting a 5.37% increase from the previous year[7] - The company reported a total current asset of RMB 25.89 billion as of September 30, 2025, compared to RMB 19.47 billion at the end of 2024, reflecting a 32.9% increase[22] - The company's total liabilities decreased to RMB 50.38 billion as of September 30, 2025, from RMB 51.64 billion at the end of 2024, a reduction of 2.4%[24] - The company reported cash payments for investments totaling $662,714,173 in 2025, with no comparable figure for 2024, suggesting a new investment strategy[29] Operational Efficiency - The company attributed the increase in net profit to improved operational efficiency and reduced cash payments for raw materials and services[10] - The company is actively implementing technical cost reduction projects to support operational performance improvement[18] - The company plans to enhance operational efficiency by optimizing marketing strategies and improving product structure[20] - The company is focusing on deepening reforms and innovations to manage costs and improve operational performance[20] Production and Sales - The company produced 14.12 million tons of pig iron, 15.26 million tons of crude steel, and 14.47 million tons of steel products from January to September 2023[17] - New product sales reached approximately 1.32 million tons, with gross profit from new products increasing by 113% year-on-year[18] - The company has launched three new products, including high-strength 2200MPa aluminum-silicon coated hot-formed steel, marking their domestic debut[18] Cost Management - The company achieved a reduction in fuel ratio by 9 kg/t and coke ratio by 8 kg/t compared to Q1 2025, supporting low-carbon production and cost control[17] - The incidence of waste and defective products decreased by 0.65 percentage points and 0.71 percentage points, respectively, compared to Q1 2025[18] - The company achieved a cost reduction of RMB 190 million through 46 planned energy-saving measures by the end of September 2025[19] - The company reported a decrease in cash paid for purchasing goods and services to RMB 47.99 billion in 2025 from RMB 52.62 billion in 2024, a reduction of 8.83%[28] Recognition and Awards - The company has received recognition as a "Carbon Peak and Carbon Neutrality Benchmark Enterprise" and won a special award for innovative achievements in carbon neutrality[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 131,371[11] - The equity attributable to shareholders increased by 3.44% to CNY 24,057,112,997 compared to the previous year[7] - The company reported a total equity attributable to shareholders of RMB 24.06 billion as of September 30, 2025, compared to RMB 23.26 billion at the end of 2024, an increase of 3.4%[24]
东方电气(01072) - 2025 Q3 - 季度业绩
2025-10-30 14:42
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責,對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 東方電氣股份有限公司 馮 勇 聯席公司秘書 中國‧四川省‧成都 2025年10月30日 2025年第三季度報告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.09條和第 13.10B條及香港法例第571章證券及期貨條例第XIVA部 刊 發。 下文載列截至2025年9月30日止九個月(「報告期」)東方電氣股份有限公司(「公 司」或「東方電氣」)及 其 附 屬 公 司 的2025年 第 三 季 度 報 告。該 報 告 所 載 的 財 務 報 告 乃 根 據 中 國 企 業 會 計 準 則 編 製,且 未 經 審 計。 本 公 告 以 中 英 文 兩 種 語 言 編 製。如 中 英 文 版 本 有 任 何 歧 義,概 以 中 文 版 本 為 準。 承董事會命 – 1 – 於 本 公 告 刊 發 日 期,公 司 董 事 如 下: 非 執 ...
春立医疗(01858) - 2025 Q3 - 季度业绩
2025-10-30 14:40
Financial Performance - The company's operating revenue for the third quarter reached CNY 268,497,491.74, representing a year-on-year increase of 109.51%[8] - The total profit for the period was CNY 84,476,176.70, with a year-to-date profit of CNY 211,788,696.95, reflecting a significant increase of 220.09% compared to the previous year[8] - Net profit attributable to shareholders was CNY 77,061,913.60 for the quarter, and CNY 191,531,404.47 year-to-date, marking a 213.21% increase year-on-year[8] - The basic earnings per share for the quarter was CNY 0.20, with a year-to-date figure of CNY 0.50, showing a growth of 212.50%[9] - The company reported a net cash flow from operating activities of CNY 174,567,044.11 year-to-date, indicating improved cash management[8] - Total operating revenue for the first three quarters of 2025 reached ¥756,093,897.40, compared to ¥508,283,661.62 in the same period of 2024, indicating a significant increase[25] - Net profit for the first three quarters of 2025 reached CNY 191,612,423.86, a significant increase from CNY 61,008,648.47 in the same period of 2024, representing a growth of approximately 213%[26] - Operating profit for the first three quarters of 2025 was CNY 211,727,931.57, compared to CNY 65,450,654.17 in 2024, indicating an increase of about 223%[26] - The total comprehensive income for the first three quarters of 2025 was CNY 191,612,423.86, compared to CNY 61,008,648.47 in 2024, showing a growth of approximately 213%[27] Research and Development - Research and development expenses totaled CNY 35,618,326.74 for the quarter, accounting for 13.27% of operating revenue, a decrease from 11.71% in the previous year[9] - Research and development expenses for the first three quarters of 2025 amounted to ¥86,472,598.27, compared to ¥99,676,406.70 in the same period of 2024, showing a decrease[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 6,164, with 6,149 A-share holders and 15 H-share holders[18] - The largest shareholder, Shi Chunbao, holds 120,209,043 shares, representing 31.34% of the total shares[16] - The second-largest shareholder, Yue Shujun, holds 95,447,900 shares, accounting for 24.88% of the total shares[17] - Beijing Panmao Investment Management Co., Ltd. holds 17,250,000 shares, representing 4.50% of the total shares[17] - The report indicates that there are no known relationships or concerted actions among the top shareholders[18] - The company has not received any notifications regarding changes in the lending or borrowing of shares among the top shareholders[19] Dividend Distribution - The company plans to distribute a cash dividend of 2.10 RMB per 10 shares, amounting to a total of 80,260,246.29 RMB, which represents 41.90% of the net profit attributable to ordinary shareholders[20] - The total share capital as of September 30, 2025, is 383,568,500 shares, with 1,376,851 shares held in the A-share repurchase account excluded from the profit distribution[20] - The company does not plan to convert capital reserves into share capital or issue bonus shares in the current profit distribution plan[20] - The cash dividend distribution plan is subject to approval at the company's first extraordinary general meeting in 2025[20] Asset and Liability Management - Total assets at the end of the reporting period were CNY 3,540,324,901.27, an increase of 2.15% from the previous year[9] - The total current assets as of September 30, 2025, were ¥2,900,888,254.67, an increase from ¥2,840,481,126.00 at the end of 2024[22] - The total liabilities decreased to ¥554,084,889.04 as of September 30, 2025, down from ¥644,390,846.18 at the end of 2024[23] - The total assets as of September 30, 2025, were ¥3,540,324,901.27, compared to ¥3,465,734,982.98 at the end of 2024, indicating growth[23] - Cash and cash equivalents as of September 30, 2025, were ¥1,109,889,349.24, slightly down from ¥1,139,778,517.24 at the end of 2024[22] - Cash and cash equivalents at the end of the reporting period were CNY 1,105,901,679.78, down from CNY 1,155,205,573.66 at the end of the previous year[30] Operational Strategy - The company attributes revenue growth to the integration of product lines into centralized procurement and a focus on product innovation and international development strategies[14] - The company plans to continue optimizing resource allocation and enhancing operational management to sustain profit growth[14] Cash Flow and Investment - Cash flow from operating activities generated a net amount of CNY 174,567,044.11, a turnaround from a negative cash flow of CNY 17,279,413.75 in the previous year[29] - Investment activities resulted in a net cash outflow of CNY 180,050,292.79, compared to a net inflow of CNY 50,828,134.57 in the same period of 2024[29] - The company incurred credit impairment losses of CNY 13,646,674.50, compared to CNY 7,060,926.86 in the previous year, indicating an increase in credit risk[26] - The company reported a decrease in accounts payable to ¥178,184,791.15 from ¥227,845,174.60 in the previous year[23] - The company reported a decrease in cash outflows related to employee payments, which amounted to CNY 149,971,256.13, down from CNY 195,375,092.18 in the previous year[29]